Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 7 results.
User Information
Export Records
  1. 1.   Therapeutic modulation of Akt activity and antitumor efficacy of interleukin-12 against orthotopic murine neuroblastoma
  2. Khan, T.; Hixon, J. A.; Stauffer, J. K.; Lincoln, E.; Back, T. C.; Brenner, J.; Lockett, S.; Nagashima, K.; Powell, D.; Wigginton, J. M.
  3. Journal of the National Cancer Institute. 2006, FEB 1; 98(3): 190-202.
  1. 2.   Multicolor fluorescence-based approaches for imaging cytokine-induced alterations in the neovascularization, growth, metastasis, and apoptosis of murine neuroblastoma tumors
  2. Stauffer, J. K.; Khan, T.; Salcedo, R.; Hixon, J. A.; Lincoln, E.; Back, T. C.; Wigginton, J. M.
  3. Journal of Immunotherapy. 2006, MAR-APR; 29(2): 151-164.
  1. 3.   Treatment of mice with IL-12 DNA constructs leads to augmented NK activity in lungs but low IFN-gamma release - Implications for Bordetella pertussis infections following aerosol challenge
  2. Carter, C. R. D.; Dagg, B. M.; Whitmore, K. M.; Keeble, J. R.; Asokanathan, C.; Rodgers, A.; Watanabe, M.; Xing, D.; Walker, K. B.
  3. Cytokine. 2005, MAY 7; 30(3): 100-108.
  1. 4.   Toxicity vs antitumor effects of hydrodynamic IL-12 (interleukin-12) and IL-18 cDNA injections
  2. Rodriguez-Galan, M. C.; Watanabe, M.; Young, H. A.
  3. Faseb Journal. 2005, MAR 7; 19(5, Part 2, Suppl. S): A1406-A1406.
  1. 5.   Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages
  2. Cho, H.; Lasco, T. M.; Allen, S. S.; Yoshimura, T.; McMurray, D. N.
  3. Infection and Immunity. 2005, MAR; 73(3): 1367-1376.
  1. 6.   Anti-interleukin-12 antibody for active Crohn's disease
  2. Mannon, P. J.; Fuss, I. J.; Mayer, L.; Elson, C. O.; Sandborn, W. J.; Present, D.; Dolin, B.; Goodman, N.; Groden, C.; Hornung, R. L.; Quezado, M.; Neurath, M. F.; Salfeld, J.; Veldman, G. M.; Schwertschlag, U.; Strober, W.
  3. New England Journal of Medicine. 2004, NOV 11; 351(20): 2069-2079.
  1. 7.   Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis
  2. Smyth, M. J.; Cretney, E.; Takeda, K.; Wiltrout, R. H.; Sedger, L. M.; Kayagaki, N.; Yagita, H.; Okumura, K.
  3. Journal of Experimental Medicine. 2001 193(6): 661-670.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel